Cooper Companies (COO) Expected to Announce Earnings on Wednesday

Posted by George Bondi on Sep 7th, 2026

Cooper Companies (NASDAQ:COO – Get Free Report) is expected to post its Q3 2026 results after the market closes on Wednesday, September 9th. Analysts expect the company to post earnings of $1.12 per share and revenue of $1.0984 billion for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2026 earning results page for the latest details on the call scheduled for Wednesday, September 9, 2026 at 5:00 PM ET.

Cooper Companies (NASDAQ:COO – Get Free Report) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.96 EPS. On average, analysts expect Cooper Companies to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Cooper Companies Price Performance

Shares of COO stock opened at $69.59 on Monday. The stock has a market cap of $13.57 billion, a price-to-earnings ratio of 58.97, a PEG ratio of 1.82 and a beta of 0.82. The business’s fifty day moving average is $72.71 and its 200 day moving average is $70.36. Cooper Companies has a twelve month low of $58.89 and a twelve month high of $89.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Hedge Funds Weigh In On Cooper Companies

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. CYBER HORNET ETFs LLC bought a new stake in shares of Cooper Companies in the 2nd quarter worth $36,000. MUFG Securities EMEA plc bought a new position in shares of Cooper Companies during the second quarter valued at $42,000. IFP Advisors Inc lifted its holdings in shares of Cooper Companies by 2,647.8% during the third quarter. IFP Advisors Inc now owns 632 shares of the medical device company’s stock valued at $43,000 after purchasing an additional 609 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Cooper Companies during the third quarter valued at $59,000. Finally, Quarry LP purchased a new stake in shares of Cooper Companies during the fourth quarter valued at $70,000. 24.39% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on COO. Wells Fargo & Company reaffirmed a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Robert W. Baird decreased their target price on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday, June 5th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Finally, Stifel Nicolaus cut their price target on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, Cooper Companies has an average rating of “Hold” and a consensus target price of $81.64.

View Our Latest Stock Report on COO

Cooper Companies Company Profile

(Get Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.